# Textron Inc: financial statements, quarterly

TXT · NYSE · CIK 217346 · [Industrials](/sectors/industrials.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/txt.md) · [Financials](/companies/txt/financials.md) · [Filings](/companies/txt/filings.md) · [Insiders](/companies/txt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/txt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,343](/filings/0000217346-24-000092.md) | [3,892 d](/filings/0000217346-26-000006.md) | [3,135](/filings/0000217346-25-000046.md) | [3,527](/filings/0000217346-25-000068.md) | [3,427](/filings/0000217346-25-000077.md) | [3,613 d](/filings/0000217346-26-000006.md) | [3,306](/filings/0000217346-26-000012.md) | [3,716](/filings/0000217346-26-000036.md) | [3,602](/filings/0000217346-25-000077.md) | [4,175 d](/filings/0000217346-26-000006.md) | [3,695](/filings/0000217346-26-000012.md) | [3,827](/filings/0000217346-26-000036.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | not reported | not reported | [144](/filings/0000217346-25-000046.md) | [105](/filings/0000217346-25-000068.md) | [126](/filings/0000217346-25-000077.md) | [116 d](/filings/0000217346-26-000006.md) | [132](/filings/0000217346-26-000012.md) | [137](/filings/0000217346-26-000036.md) | [118](/filings/0000217346-25-000077.md) | [134 d](/filings/0000217346-26-000006.md) | [120](/filings/0000217346-26-000012.md) | [116](/filings/0000217346-26-000036.md) |
| Selling, general and administrative | $m | [303](/filings/0000217346-24-000092.md) | [328 d](/filings/0000217346-26-000006.md) | [316](/filings/0000217346-25-000046.md) | [293](/filings/0000217346-25-000068.md) | [282](/filings/0000217346-25-000077.md) | [265 d](/filings/0000217346-26-000006.md) | [298](/filings/0000217346-26-000012.md) | [303](/filings/0000217346-26-000036.md) | [257](/filings/0000217346-25-000077.md) | [315 d](/filings/0000217346-26-000006.md) | [321](/filings/0000217346-26-000012.md) | [311](/filings/0000217346-26-000036.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [32.0](/filings/0000217346-24-000092.md) | [31.0 d](/filings/0000217346-26-000006.md) | [36.0](/filings/0000217346-25-000046.md) | [63.0](/filings/0000217346-25-000068.md) | [29.0](/filings/0000217346-25-000077.md) | [(10.0) d](/filings/0000217346-26-000006.md) | [34.0](/filings/0000217346-26-000012.md) | [56.0](/filings/0000217346-26-000036.md) | [81.0](/filings/0000217346-25-000077.md) | [43.0 d](/filings/0000217346-26-000006.md) | [47.0](/filings/0000217346-26-000012.md) | [56.0](/filings/0000217346-26-000036.md) |
| Net income | $m | [269](/filings/0000217346-24-000092.md) | [198 d](/filings/0000217346-26-000006.md) | [201](/filings/0000217346-25-000046.md) | [259](/filings/0000217346-25-000068.md) | [223](/filings/0000217346-25-000077.md) | [141 d](/filings/0000217346-26-000006.md) | [207](/filings/0000217346-26-000012.md) | [245](/filings/0000217346-26-000036.md) | [234](/filings/0000217346-25-000077.md) | [235 d](/filings/0000217346-26-000006.md) | [220](/filings/0000217346-26-000012.md) | [248](/filings/0000217346-26-000036.md) |
| Diluted EPS | $ per share | not reported | not reported | [1.03](/filings/0000217346-25-000046.md) | not reported | not reported | not reported | [1.13](/filings/0000217346-26-000012.md) | [1.35](/filings/0000217346-26-000036.md) | not reported | not reported | [1.25](/filings/0000217346-26-000012.md) | [1.42](/filings/0000217346-26-000036.md) |
| Basic EPS | $ per share | not reported | not reported | [1.04](/filings/0000217346-25-000046.md) | not reported | not reported | not reported | [1.14](/filings/0000217346-26-000012.md) | [1.36](/filings/0000217346-26-000036.md) | not reported | not reported | [1.26](/filings/0000217346-26-000012.md) | [1.43](/filings/0000217346-26-000036.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [16.5](/filings/0000217346-23-000033.md) | [16.9](/filings/0000217346-25-000017.md) | [16.4](/filings/0000217346-24-000052.md) | [16.4](/filings/0000217346-24-000084.md) | [16.5](/filings/0000217346-24-000092.md) | [16.8](/filings/0000217346-26-000006.md) | [16.9](/filings/0000217346-25-000046.md) | [17.1](/filings/0000217346-25-000068.md) | [17.4](/filings/0000217346-25-000077.md) | [18.1](/filings/0000217346-26-000036.md) | [18.1](/filings/0000217346-26-000012.md) | [18.1](/filings/0000217346-26-000036.md) |
| Total liabilities | $bn | [9.4](/filings/0000217346-23-000033.md) | [9.9](/filings/0000217346-25-000017.md) | [9.5](/filings/0000217346-24-000052.md) | [9.6](/filings/0000217346-24-000084.md) | [9.5](/filings/0000217346-24-000092.md) | [9.6](/filings/0000217346-26-000006.md) | [9.7](/filings/0000217346-25-000046.md) | [9.6](/filings/0000217346-25-000068.md) | [9.9](/filings/0000217346-25-000077.md) | [10.3](/filings/0000217346-26-000036.md) | [10.1](/filings/0000217346-26-000012.md) | [10.1](/filings/0000217346-26-000036.md) |
| Shareholders' equity | $bn | [7.1](/filings/0000217346-24-000092.md) | [7.0](/filings/0000217346-26-000006.md) | [6.9](/filings/0000217346-25-000068.md) | [6.9](/filings/0000217346-25-000077.md) | [7.0](/filings/0000217346-25-000077.md) | [7.2](/filings/0000217346-26-000036.md) | [7.3](/filings/0000217346-26-000036.md) | [7.4](/filings/0000217346-26-000036.md) | [7.5](/filings/0000217346-25-000077.md) | [7.9](/filings/0000217346-26-000036.md) | [8.0](/filings/0000217346-26-000036.md) | [8.1](/filings/0000217346-26-000036.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [258 d](/filings/0000217346-24-000092.md) | [549 d](/filings/0000217346-26-000006.md) | [(7.0)](/filings/0000217346-25-000046.md) | [367 d](/filings/0000217346-25-000068.md) | [208 d](/filings/0000217346-25-000077.md) | [446 d](/filings/0000217346-26-000006.md) | [(124)](/filings/0000217346-26-000012.md) | [387 d](/filings/0000217346-26-000036.md) | [349 d](/filings/0000217346-25-000077.md) | [700 d](/filings/0000217346-26-000006.md) | [(117)](/filings/0000217346-26-000012.md) | [304 d](/filings/0000217346-26-000036.md) |
| Capital expenditure | $m | [79.0 d](/filings/0000217346-24-000092.md) | [178 d](/filings/0000217346-26-000006.md) | [66.0](/filings/0000217346-25-000046.md) | [74.0](/filings/0000217346-25-000068.md) | [71.0](/filings/0000217346-25-000077.md) | [153 d](/filings/0000217346-26-000006.md) | [56.0](/filings/0000217346-26-000012.md) | [78.0](/filings/0000217346-25-000068.md) | [76.0](/filings/0000217346-25-000077.md) | [173 d](/filings/0000217346-26-000006.md) | [133](/filings/0000217346-26-000012.md) | [95.0 d](/filings/0000217346-26-000036.md) |
| Dividends paid | $m | [4.0 d](/filings/0000217346-24-000092.md) | [4.0 d](/filings/0000217346-26-000006.md) | [4.0](/filings/0000217346-25-000046.md) | [4.0 d](/filings/0000217346-25-000068.md) | [0.0 d](/filings/0000217346-25-000077.md) | [4.0 d](/filings/0000217346-26-000006.md) | [3.0](/filings/0000217346-26-000012.md) | [4.0 d](/filings/0000217346-26-000036.md) | [4.0 d](/filings/0000217346-25-000077.md) | [7.0 d](/filings/0000217346-26-000006.md) | [3.0](/filings/0000217346-26-000012.md) | [4.0 d](/filings/0000217346-26-000036.md) |
| Share repurchases | $m | [235 d](/filings/0000217346-24-000092.md) | [283 d](/filings/0000217346-26-000006.md) | [317](/filings/0000217346-25-000046.md) | [358 d](/filings/0000217346-25-000068.md) | [215 d](/filings/0000217346-25-000077.md) | [232 d](/filings/0000217346-26-000006.md) | [215](/filings/0000217346-26-000012.md) | [214 d](/filings/0000217346-26-000036.md) | [206 d](/filings/0000217346-25-000077.md) | [187 d](/filings/0000217346-26-000006.md) | [168](/filings/0000217346-26-000012.md) | [209 d](/filings/0000217346-26-000036.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [213](/filings/0000217346-23-000033.md) | [207](/filings/0000217346-24-000052.md) | [203](/filings/0000217346-24-000084.md) | [200](/filings/0000217346-24-000092.md) | [195](/filings/0000217346-25-000046.md) | [192](/filings/0000217346-25-000068.md) | [189](/filings/0000217346-25-000077.md) | [184](/filings/0000217346-26-000012.md) | [181](/filings/0000217346-26-000036.md) | [179](/filings/0000217346-25-000077.md) | [176](/filings/0000217346-26-000012.md) | [175](/filings/0000217346-26-000036.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 171,986,917 at 2026-07-17, from the cover of the [10-Q filed 2026-07-28](/filings/0000217346-26-000036.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.